Latest Breaking News On - Andrew leach maria shiryaevskaya - Page 1 : comparemela.com

(1) MOSCOW, July 30, 2021 /PRNewswire/ The Russian Direct Investment Fund (RDIF, Russia s sovereign wealth fund) announces initial safety results of the world s first study of a combination between the AstraZeneca vaccine (developed jointly with the University of Oxford) and the first component of the Sputnik V vaccine (Sputnik Light vaccine based on human adenovirus serotype 26) in the Republic of Azerbaijan. The heterogeneous boosting approach ( vaccine cocktail using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component) was at the core of Sputnik V, the world s first registered vaccine against coronavirus. With this approach proving successful in creating a longer and more durable immunity against the coronavirus, RDIF took the lead in initiating partnerships with other vaccine producers to conduct joint studies of a combination of the first component of Sputnik V with foreign vaccines.

Republic of azerbaijanRussian federationAndrew leach maria shiryaevskayaAlexey urazovIrina panarinaKirill dmitrievVladimir putinHudson sandlerUniversity of oxfordR pharm groupGamaleya centerRussian direct investment fundSputnik lightRussia vladimirGeneral managerAstrazeneca russia